OncoImmune: OncoImmune's SACCOVID demonstrates significant therapeutic efficacy in Covid-19 trial

The trial's top-line data from 203 participants demonstrate that severe or critical Covid-19 patients treated with SACCOVID witnessed speedy recovery and a significant reduction in disease progression to The post OncoImmune's SACCOVID demonstrates significant therapeutic efficacy in Covid-19 trial appeared first on Pharmaceutical Business review.